STOCK TITAN

Arrowhead officer proposes $934K share sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144/A

Rhea-AI Filing Summary

Arrowhead Pharmaceuticals, Inc. officer Daniel Apel reported a proposed sale of 13,095 common shares, with an aggregate market value of $934,206.16 and an approximate sale date of April 22, 2026. The amendment adds a Rule 10b5-1 plan adoption date of September 16, 2025. Merrill Lynch is named as broker.

Proposed shares to be sold 13,095 shares Approximate sale date: April 22, 2026
Aggregate market value $934,206.16 Proposed sale
Shares outstanding 140,032,190 shares Issuer share count stated in the notice
Bonus shares acquired 100,000 shares Acquired April 15, 2025
10b5-1 regulatory
"10b5-1 adoption date"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Aggregate Market Value financial
"Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Number of Shares or Other Units Outstanding financial
"Number of Shares or Other Units Outstanding"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ARWR shares did Daniel Apel report for sale?

Daniel Apel reported a proposed sale of 13,095 common shares, with an aggregate market value of $934,206.16. The approximate sale date is April 22, 2026, and Merrill Lynch is named as broker.

How did Daniel Apel acquire the shares listed in the notice?

The notice lists a 100,000-share bonus acquisition dated April 15, 2025. It identifies compensation as the nature of payment and April 22, 2026 as the payment date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144/A: Filer Information

144/A: Issuer Information

144/A: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

144/A: Remarks and Signature

Keep reading